Policy & Advocacy MassBio Op-Ed in STAT: How to keep the BIOSECURE Act from hobbling U.S. biotech and pharma Sep 12, 2024
Announcements Statement from MassBio CEO and President on the end of the legislative session Aug 01, 2024
Policy & Advocacy MassBio testifies in support of H.B. 4459’s Life Sciences Initiative reauthorization May 07, 2024
Policy & Advocacy State leaders highlight intersection of policy, partnerships, and patients at MassBio Breakfast Feb 08, 2024
Policy & Advocacy Patients, Policy and the IRA: Navigating an Evolving Federal Landscape Dec 21, 2023
Policy & Advocacy Team Massachusetts’ win on ARPA-H is a win for innovation and patients Oct 10, 2023
Announcements Statement from MassBio CEO & President Kendalle Burlin O’Connell on ARPANET-H announcement Sep 26, 2023
